← Back to all trials
Not Yet Recruiting
NCT05621577
Obstructive Sleep Apnea Patients Treated With Mandibular Advancement Device
Conditions: Sleep Apnea, Obstructive
Sex: All
Ages: 25 Years – 50 Years
Phase: NA
Enrollment: 20
Sponsor: Hawler Medical University
Location: Iraq
Summary
The purpose of this study is to evaluate efficacy of mandibular advancement device (MAD).
on treating obstructive sleep apneas, symptoms, Apnea/Hypopnea Index (QHI) and the Respiratory Arousal Index (AHI/REI) and peripheral capillary oxygen saturation (SpO2) Range, PULSE in patients with mild to moderate obstructive sleep apnea/hypopnea syndrome, and evaluating potential dental side effects
Eligibility Criteria
Inclusion Criteria:sample will be taken from Kurdish population in Erbil city.Obstructive sleep apnea, apnea-hypopnea index of <30 with excessive daytime sleepinessExclusion Criteria:People with problems in nasal part of airway.People with cleft lip and palatePatient who did tonsillectomy and / or other pharyngeal operations.People who take any kind of sleep medication.Temporomandibular Disorders.People with periodontal disease.Less than 8 teeth/ arch.
Source: ClinicalTrials.gov (NCT05621577). StuddyBuddy aggregates publicly available trial information.